Hep C drug trial deemed a success
17 March, 2016Shares in Biotron rose almost 60% as the company confirmed positive outcomes from its Phase 2 study of antiviral drug BIT225 in Hepatitis C patients.
POC diagnostics market to reach almost $3 billion by 2021
14 March, 2016GlobalData has projected that the point-of-care (POC) diagnostics market will experience solid growth from $2.13 billion in 2015 to just under $3 billion by 2021, representing a compound annual growth rate (CAGR) of 5.3%.
Innovation fund attracting foreign investment, says fund manager
10 March, 2016The Prime Minister's $500 million innovation fund has already attracted significant international interest and will attract offshore investment to the country, according to life sciences fund manager Jeremy Curnock Cook.
Blood pressure drug boosts the effect of chemo
10 March, 2016Scientists have discovered that a drug developed to treat high blood pressure has a powerful 'chemo-boosting' effect when combined with certain chemotherapeutic drugs for the treatment of angiosarcoma.
Regenerative medicine to treat leg ulcers
09 March, 2016Avita Medical has reported positive results from its multicentre clinical trial of ReGenerCell in the treatment of chronic venous leg ulcers (VLUs).
Second US patent for Australian immunoassay technology
26 February, 2016Adelaide biotechnology company TGR BioSciences has received its second US patent in six months, covering key aspects of the company's CaptSure immunoassay technology.
Recruitment now open for bone bruising trial
23 February, 2016Paradigm Biopharmaceuticals seeks to investigate if the drug ZILOSUL can resolve bone bruising arising from sporting or accidental injuries to the knee such as a ruptured anterior cruciate ligament (ACL).
Nerve stimulation studies for migraine sufferers
22 February, 2016electroCore is running two new trials of its gammaCore non-invasive vagus nerve stimulation (nVNS) therapy in episodic migraine.
Avita appoints new distributor, sells respiratory business
17 February, 2016Regenerative medicine company Avita Medical has appointed MSM Medical as its newest European distributor and sold its respiratory business to Medical Developments International.
Spinifex condoms — thinner than a human hair
12 February, 2016 by Adam FloranceThe secret to the world's thinnest, strongest latex condoms and surgical gloves may lie in the resin from spinifex grass.
Progress towards an all-in-one disease monitoring device
10 February, 2016Australian and British scientists are collaborating on the creation of a single miniature biodegradable device that can not only track a disease, but can also treat it.
Portable splint to be launched this year
09 February, 2016With the support of the Medical Device Partnering Program, Fluoro Medical will this year launch a foldable splint that can fit into a first aid kit.
Australian cancer drug licensed for $730m
01 February, 2016A promising new cancer drug, developed by the Cancer Therapeutics CRC (CTx), has been licensed to pharmaceutical company MSD for $730 million.
Proposed stem cell trial on track for approval
29 January, 2016Cynata Therapeutics has received favourable advice from the UK Medicines and Healthcare products Regulatory Agency, causing shares in the regenerative medicine company to jump by over 20%.
The eyes have it — bionically
28 January, 2016 by Adam FloranceUNSW engineers have developed a bionic eye with the potential to aid the blind in the same way that the cochlear implant has aided the deaf.
